These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26562037)

  • 21. [Results of studies using the indirect immunofluorescence methods (antinuclear factors) in various rheumatic entities].
    Ripoll Gómez M
    Rev Esp Reum Enferm Osteoartic; 1975; 18(1):65-9. PubMed ID: 1094511
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic utility of automated indirect immunofluorescence compared to manual indirect immunofluorescence for anti-nuclear antibodies in patients with systemic rheumatic diseases: A systematic review and meta-analysis.
    Kim J; Lee W; Kim GT; Kim HS; Ock S; Kim IS; Jeong S
    Semin Arthritis Rheum; 2019 Feb; 48(4):728-735. PubMed ID: 29706242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antinuclear antibodies: what dermatologists need to know].
    Guillaud C; Hüe S; Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2013 Dec; 140(12):821-6. PubMed ID: 24315232
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: results from a long-term follow-up Scandinavian multicentre study.
    Compagno M; Jacobsen S; Rekvig OP; Truedsson L; Heegaard NH; Nossent J; Jönsen A; Jacobsen RS; Eilertsen GØ; Sturfelt G; Bengtsson AA
    Scand J Rheumatol; 2013; 42(4):311-6. PubMed ID: 23496224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients].
    Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H
    Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases].
    Kim JM; Ihm CH; Sin DH; Ihm MK; Sim SC
    Korean J Lab Med; 2008 Oct; 28(5):353-61. PubMed ID: 18971616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
    Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
    Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reconstructing a 3-dimensional image of the results of antinuclear antibody testing by indirect immunofluorescence.
    Murai R; Yamada K; Tanaka M; Kuribayashi K; Kobayashi D; Tsuji N; Watanabe N
    J Immunol Methods; 2013 Jan; 387(1-2):312-6. PubMed ID: 23073364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients].
    Nebe H; Blume N
    Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251
    [No Abstract]   [Full Text] [Related]  

  • 31. The dense fine speckled antinuclear antibody pattern in autoimmune rheumatic disease: comment on the article by Mariz et al.
    Craig WY; Ledue TB
    Arthritis Rheum; 2011 Jun; 63(6):1759; author reply 1760. PubMed ID: 21425126
    [No Abstract]   [Full Text] [Related]  

  • 32. Antinuclear antibody testing. A study of clinical utility.
    Slater CA; Davis RB; Shmerling RH
    Arch Intern Med; 1996 Jul; 156(13):1421-5. PubMed ID: 8678710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antinuclear antibody (ANA) profile testing of ANA- positive patients.
    Hauksdóttir GS; Jónsson T; Mellbye OJ
    Clin Rheumatol; 2001; 20(2):157-8. PubMed ID: 11346233
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of a Computer-Aided Microscope System and Its Anti-Nuclear Antibody Test Kit for Indirect Immunofluorescence Assay].
    Hayashi N; Saegusa J; Uto K; Oyabu C; Saito T; Sato I; Kawano S; Kumagai S
    Rinsho Byori; 2016 Feb; 64(2):142-51. PubMed ID: 27311277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinuclear antibody test.
    O'Sullivan M; McLean-Tooke A; Loh RK
    Aust Fam Physician; 2013 Oct; 42(10):718-21. PubMed ID: 24130974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
    Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
    Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of anti-dsDNA antibody screening with chemiluminescence followed by confirmation by indirect immunofluorescence.
    Callado MR; Lima JR; Barroso MN; Pinheiro AT; da Cruz Neto MF; Abreu MA; Vieira WP
    Rev Bras Reumatol; 2013; 53(5):412-8. PubMed ID: 24316898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An italian multicenter study for application of a diagnostic algorithm in autoantibody testing.
    Bonaguri C; Melegari A; Dall'Aglio P; Ballabio A; Terenziani P; Russo A; Battistelli L; Aloe R; Camisa R; Campaniello G; Sartori E; Monica C
    Ann N Y Acad Sci; 2009 Sep; 1173():124-9. PubMed ID: 19758140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
    Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
    J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.